Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology.
about
Laser vaccine adjuvants. History, progress, and potentialMicro-fractional epidermal powder delivery for improved skin vaccinationTranscutaneous vaccination via laser microporation.Skin permeation of small-molecule drugs, macromolecules, and nanoparticles mediated by a fractional carbon dioxide laser: the role of hair follicles.Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines.Impact of different vehicles for laser-assisted drug permeation via skin: full-surface versus fractional ablation.An update on the use of laser technology in skin vaccination.Effective and lesion-free cutaneous influenza vaccinationRapid fibrin plug formation within cutaneous ablative fractional CO2 laser lesions.Fractional laser-assisted drug delivery: Laser channel depth influences biodistribution and skin deposition of methotrexate.Laser assisted Drug Delivery: Grundlagen und Praxis.Laser-assisted drug delivery: mode of action and use in daily clinical practice.Noninvasive Transdermal Vaccination Using Hyaluronan Nanocarriers and Laser Adjuvant.Fractional laser-assisted topical delivery leads to enhanced, accelerated and deeper cutaneous 5-fluorouracil uptake.Transcutaneous drug delivery by liposomes using fractional laser technology.Sustained epidermal powder drug delivery via skin microchannels.Laser-induced thermal coagulation enhances skin uptake of topically applied compounds.Vehicle type affects filling of fractional laser-ablated channels imaged by optical coherence tomography.Fractional laser-assisted percutaneous drug delivery via temperature-responsive liposomes.Transdermal delivery of human growth hormone via laser-generated micropores.Transcutaneous antigen delivery system.Lasers as an approach for promoting drug delivery via skin.Update of Ablative Fractionated Lasers to Enhance Cutaneous Topical Drug Delivery.Fractional laser exposure induces neutrophil infiltration (N1 phenotype) into the tumor and stimulates systemic anti-tumor immune response.Fractional thermolysis by bipolar radiofrequency facilitates cutaneous delivery of peptide and siRNA with minor loss of barrier function.
P2860
Q30413501-CFA5586E-25C3-4E5A-898C-ED54B017953AQ34229340-82C266E0-D91E-47BB-8E5F-7B4A2DBC0838Q34323166-8AFC87CF-FC00-49CA-BBF3-F46247D87DDFQ34471349-8C370F47-E95D-4EC7-9CA6-0A76F5CD850AQ34593082-F19F6620-25B2-4080-AB1B-3888C69BAC19Q34983358-F5192904-EC43-4593-B6F4-F79A476937C6Q35017651-1D89A49C-5C6B-41E3-9727-123A41034763Q35549338-27199B9C-BB3B-428F-B731-81954D490388Q35781531-64AA07FB-CAB6-4269-99B0-EF8BDD5EB65FQ35914864-2543CDB7-FFC4-43FF-A4C0-94EBD92FC24EQ36000662-1619BFBC-FB1D-4228-AA36-F2EBDF8705F1Q36000667-34EAC690-51B9-430E-B9C9-820F0B2D03A8Q36189410-D6798083-0712-436F-A872-D26BD8837E5CQ36190101-F8E1A832-53CA-428A-B6D5-96D738FE2CDBQ36227719-7C798037-1DC2-4F66-B6BB-60D6F71A43C6Q36263427-F58FB4C3-B53A-4EA6-8B26-A28BB0FED3D0Q36274991-32773214-48E2-4D41-8E46-ED7075BC5543Q36284692-50EA9180-5A85-4D75-A967-B4FC95F70C60Q36301922-EF5878B6-4B06-45F9-94D0-D0916BF02B73Q36315782-D24C535F-9254-45A6-8779-F63AA342B3C7Q38076804-FD87C575-2F43-4B4D-89A2-002D3336FAA0Q38184607-F5882524-BAF2-4076-8926-EE06696E8E43Q39422126-CD16E911-2C65-4717-ACC5-9C28C34A79F5Q41702460-2732F264-75FA-4823-9170-CEAE7EEEE83BQ53393012-8CB4C0C8-EBAC-4C23-8590-7643CDD640F1
P2860
Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Facilitation of transcutaneous ...... on by a safe laser technology.
@ast
Facilitation of transcutaneous ...... on by a safe laser technology.
@en
Facilitation of transcutaneous ...... on by a safe laser technology.
@nl
type
label
Facilitation of transcutaneous ...... on by a safe laser technology.
@ast
Facilitation of transcutaneous ...... on by a safe laser technology.
@en
Facilitation of transcutaneous ...... on by a safe laser technology.
@nl
prefLabel
Facilitation of transcutaneous ...... on by a safe laser technology.
@ast
Facilitation of transcutaneous ...... on by a safe laser technology.
@en
Facilitation of transcutaneous ...... on by a safe laser technology.
@nl
P2093
P2860
P1476
Facilitation of transcutaneous ...... on by a safe laser technology.
@en
P2093
Dieter Manstein
Dilip Shah
Garuna Kositratna
Richard R Anderson
Xinyuan Chen
P2860
P356
10.1016/J.JCONREL.2012.01.002
P407
P577
2012-01-09T00:00:00Z